Tango Therapeutics TNGX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tango Therapeutics's change in AP?
- Tango Therapeutics (TNGX) reported change in AP of $1.79M in Q1 2026.
- How has Tango Therapeutics's change in AP changed year-over-year?
- Tango Therapeutics's change in AP increased by 9.5% year-over-year, from $1.63M to $1.79M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.